Dongli Zhou

518 total citations
22 papers, 263 citations indexed

About

Dongli Zhou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Electrical and Electronic Engineering. According to data from OpenAlex, Dongli Zhou has authored 22 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Electrical and Electronic Engineering. Recurrent topics in Dongli Zhou's work include Advanced battery technologies research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Dongli Zhou is often cited by papers focused on Advanced battery technologies research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Dongli Zhou collaborates with scholars based in China, United States and Germany. Dongli Zhou's co-authors include Marcis Bajars, Patrick Schöffski, Yan Xu, Jingmin Li, John C. Morris, Hongqin Zhang, Michael A. Weber, James L. Gulley, Jun Qiu and Changjun Lv and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Power Sources and Journal of Colloid and Interface Science.

In The Last Decade

Dongli Zhou

21 papers receiving 260 citations

Peers

Countries citing papers authored by Dongli Zhou

Since Specialization

Citations

This map shows the geographic impact of Dongli Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongli Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongli Zhou more than expected).

Fields of papers citing papers by Dongli Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongli Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongli Zhou. The network helps show where Dongli Zhou may publish in the future.

Co-authorship network of co-authors of Dongli Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Dongli Zhou. A scholar is included among the top collaborators of Dongli Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongli Zhou. Dongli Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A binder-free hierarchically CoFe2O4@Fe2O3 nanoparticles anode enabling ultra-stable nickel-iron battery 2025 ·Surfaces and Interfaces ·Dongli Zhou, (unknown), Jun Huang, (unknown), (unknown), Chunlin Teng	1
2	GlycoRNA, a novel RNA modification 2025 ·Discover Oncology ·Binbin Hu, Tianyu Ma, Dongli Zhou, (unknown), (unknown)	0
3	Oxygen-defect engineering towards advanced Fe2O3 anode for high-capacity and durable Ni-Fe batteries 2025 ·Journal of Power Sources ·Chunlin Teng, Dongli Zhou, (unknown), Hongan Ma, (unknown), (unknown), Mengmeng Yang, Yinghu Dong, Xihong Lu	3
4	Multicomponent hierarchical Cu-based advanced cathode for ultrahigh capacity rechargeable Cu-Zn battery 2024 ·Journal of Alloys and Compounds ·(unknown), Dongli Zhou, Junjie Huang, (unknown), (unknown), (unknown), Chunlin Teng	2
5	Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma 2024 ·Clinical and Translational Science ·(unknown), Haiqing Dai, James S. Bourdage, Dongli Zhou, (unknown), Karey Kowalski, Carlo L. Bello, (unknown), Akash Khandelwal, Kyra J. Cowan, Jennifer Dong, Karthik Venkatakrishnan, (unknown)	4
6	An Innovative Bi₁₂SiO₂₀ Multistage Cubic Nanospheres Cathode for High‐Performance Bi//Zn Battery 2023 ·Chemistry - A European Journal ·Dongli Zhou, (unknown), (unknown), (unknown), Shiji Li, (unknown), Chunlin Teng	1
7	A space-confined strategy towards stable α/β-Bi2O3 heterojunction anode for high-energy aqueous battery 2023 ·Journal of Colloid and Interface Science ·(unknown), Dongli Zhou, Kun Tan, Shiji Li, (unknown), (unknown), Chunlin Teng, Xihong Lu	10
8	Effects of norepinephrine‑induced activation of rat vascular adventitial fibroblasts on proliferation and migration of BMSCs involved in vascular remodeling 2023 ·Experimental and Therapeutic Medicine ·(unknown), (unknown), Dongli Zhou, (unknown), (unknown), (unknown), Xiaohui Wang, Pengchao Du, Wendan Yuan	2
9	Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression 2021 ·British Journal of Cancer ·Baek‐Yeol Ryoo, Ann‐Lii Cheng, Zhenggang Ren, Tae‐You Kim, Hongming Pan, Kun-Ming Rau, Hye Jin Choi, Joong‐Won Park, Jee Hyun Kim, (unknown), Ho Yeong Lim, Dongli Zhou, Josef Straub, (unknown), Karin Berghoff, Shukui Qin	36
10	103P First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC) 2021 ·Journal of Thoracic Oncology ·Zoran Andrić, Gabriella Gálffy, Manuel Cobo, (unknown), Goran M. Stojanović, Marina Petrović, E. Felip Font, David Vicente Baz, Santiago Ponce Aix, Óscar Juan, (unknown), Zsuzsanna Szalai, György Losonczy, Antonio Calles, Reyes Bernabé, (unknown), Dongli Zhou, Andreas Schröeder, (unknown), Fortunato Ciardiello	3
11	Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study 2020 ·Journal for ImmunoTherapy of Cancer ·Claire F. Verschraegen, Guy Jérusalem, Edward F. McClay, Nicholas Iannotti, Charles H. Redfern, Jaafar Bennouna, (unknown), Karen Kelly, Janice M. Mehnert, John C. Morris, Matthew H. Taylor, David R. Spigel, Ding Wang, H. Grote, Dongli Zhou, Neru Munshi, Marcis Bajars, James L. Gulley	19
12	Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial 2019 ·Journal for ImmunoTherapy of Cancer ·Ulka N. Vaishampayan, Patrick Schöffski, Alain Ravaud, Christian Borel, (unknown), Jorge Chaves, John C. Morris, Nuria Kotecki, Martin Šmakal, Dongli Zhou, Silke Guenther, Marcis Bajars, James L. Gulley	49
13	[Relationship of TLR2 and TLR4 expressions on the surface of peripheral blood mononuclear cells to small intestinal bacteria overgrowth in patients with hepatocellular carcinoma]. 2019 ·PubMed ·Dongli Zhou, (unknown), (unknown), Xianchun Gao, Yang Liu	4
14	Dihydroartemisinin alleviates oxidative stress in bleomycin-induced pulmonary fibrosis 2018 ·Life Sciences ·(unknown), Jun Qiu, Huihui Zhou, (unknown), Dongli Zhou, Yan Xu, (unknown), (unknown), Jingmin Li, Changjun Lv, Hongqin Zhang, Wendan Yuan	58
15	Bioequivalence and Pharmacokinetics of Bisoprolol–Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects 2018 ·Clinical Drug Investigation ·Chaoying Hu, Xiao Hu, Chunhua Wang, (unknown), Dan Gao, Xiaoping Chen, Dongli Zhou, Yue Huang, Lin Li, Lan Zhang	4
16	Phase Ib trial of tepotinib in Asian patients with advanced hepatocellular carcinoma (HCC): Final data including long-term outcomes. 2017 ·Journal of Clinical Oncology ·Shukui Qin, Tae‐You Kim, Ho Yeong Lim, Baek‐Yeol Ryoo, J. Scheele, Dongli Zhou, (unknown), Ann‐Lii Cheng	3
17	Estimation of Standard Deviation for a Log-Transformed Variable Based on Summary Statistics in the Original Scale 2017 ·Statistics in Biopharmaceutical Research ·Hui Quan, Juan Zhang, Dongli Zhou, Deborah Dukovic	1
18	Blood Pressure Effects of Combined β‐Blocker and Angiotensin‐Converting Enzyme Inhibitor Therapy Compared With the Individual Agents: A Placebo‐Controlled Study With Nebivolol and Lisinopril 2012 ·Journal of Clinical Hypertension ·Michael A. Weber, Jan Basile, (unknown), (unknown), Dongli Zhou	23
19	Adaptive Patient Population Selection Design in Clinical Trials 2012 ·Statistics in Biopharmaceutical Research ·Hui Quan, Dongli Zhou, (unknown), Yi He, Gary G. Koch	5
20	Racial and Ethnic Service Use Disparities Among Homeless Adults With Severe Mental Illnesses Receiving ACT 2011 ·Psychiatric Services ·Marcela Horvitz‐Lennon, Dongli Zhou, Sharon‐Lise T. Normand, Margarita Alegrı́a, Wes Thompson	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact